Get all premium features to the best stock analysis tool

AXT, Inc. Announces Financial Conference Participation for the Second Quarter 2026

FREMONT, Calif.--(BUSINESS WIRE)---- $AXTI--AXT, Inc. (Nasdaq: AXTI), a leading manufacturer of compound semiconductor substrates, today announced that it will participate in the upcoming financial conferences: 26th Annual B. Riley Securities Institutional Investor Conference on May 21st in Los Angeles 23rd Annual Craig-Hallum Institutional Investor Conference on May 28th in Minneapolis Northland Securities Virtual Growth Conference 2026 on June 23rd About AXT, Inc. AXT is a material science company that.

AXT Announces Adjournment of 2026 Annual Meeting of Stockholders

FREMONT, Calif.--(BUSINESS WIRE)---- $AXTI--AXT, Inc. (NasdaqGS: AXTI) (the “Company” or “AXT”), a leading manufacturer of compound semiconductor wafer substrates, announced that the Company's 2026 Annual Meeting of Stockholders (the “Annual Meeting”) held on May 14, 2026 at 11:00 a.m. Pacific Time was convened and adjourned, without any business being conducted, due to lack of the required quorum. As a result of the required quorum not being present, the Annual Meeting has been adjourned to Thursday, Ju.

REX Shares Launches T-REX 2X AXTI (AXTU) ETF

MIAMI--(BUSINESS WIRE)--REX Shares ("REX") and Tuttle Capital Management ("TCM") today announce the launch of the T-REX 2X Long AXTI Daily Target ETF (Cboe: AXTU), a leveraged ETF providing 2x daily long exposure to AXT, Inc. (Nasdaq: AXTI). AXTU is designed to deliver 200% of AXTI's daily performance, giving traders a tool to engage with a global materials science company at the foundation of advanced semiconductors and optoelectronics. AXT, Inc. develops and manufactures high-performance comp.

AXT Announces Exercise of Over-Allotment Option in Public Offering of Common Stock

FREMONT, Calif.--(BUSINESS WIRE)--AXT, Inc. (NasdaqGS: AXTI) (“AXT” or the “Company”), a leading manufacturer of compound semiconductor wafer substrates, announced today that, in connection with its recently completed underwritten public offering of 8,560,311 shares of common stock, the underwriters have exercised their over-allotment option to purchase an additional 1,284,046 shares of common stock at a price to the public of $64.25 for additional gross proceeds of approximately $82.5 million,.